BUILT FOR BIOTECH
LIVE

Serial Number

88616094

Owner

PREMIER RESEARCH INTERNATIONAL LLC

Attorney

Nadya M. Sand

First Use Date

Nov 30, 2017

Filing Date

Sep 13, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BUILT FOR BIOTECH Trademark

Serial Number: 88616094 • Registration: 7646946

BUILT FOR BIOTECH is a trademark filed by PREMIER RESEARCH INTERNATIONAL LLC on September 13, 2019. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PREMIER RESEARCH INTERNATIONAL LLC (17 trademarks)

3800 PARAMOUNT PARKWAY, SUITE 400
MORRISVILLE, NC 27560

Entity Type: 16

Trademark Details

Filing Date

September 13, 2019

Registration Date

January 14, 2025

First Use Anywhere

November 30, 2017

First Use in Commerce

November 30, 2017

Published for Opposition

November 26, 2024

Goods & Services

Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, and applications for drug approval; Data management, namely, the collection, organization, management, analysis and reporting of data gathered in connection with conducting a clinical research trial for business purposes; Biostatistics consulting, namely, consulting related to the collection, summarization, and analysis of statistical information from clinical research trials and the interpretation of, and inference from, the results of such trials for use in the medical, pharmaceutical, and biotechnology industries for commercial purposes

Regulatory affairs consulting services, namely, regulatory compliance consulting in the field of medical, pharmaceutical, and biotechnology industries

Conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services for others in the field of design, planning, and implementation and project management of medical and scientific research and clinical trials; Biostatistics consulting, namely, consulting related to the collection, summarization, and analysis of statistical information from clinical research trials and the interpretation of, and inference from, the results of such trials for use in the medical, pharmaceutical, and biotechnology industries for medical or scientific research purposes; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of medical and scientific research and clinical trials; Providing quality assurance services in the field of medical and scientific research and clinical trials; Data management, namely, data encryption services, data warehousing, data migration services, data conversion of electronic information

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 14, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 14, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 29, 2024 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 7, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 5, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 10, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 7, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 8, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 1, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 10, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 10, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 10, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jul 10, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 19, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 18, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 18, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 18, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 18, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 14, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2019 NWOS
NEW APPLICATION ENTERED
Sep 17, 2019 NWAP